NAACCR Item #3942: CA 19-9 PreTX Lab Value
|Item #||Length||Source of Standard||Year Implemented||Version Implemented||Year Retired||Version Retired|
NAACCR XML: Tumor.ca199PretxLabValue
Carbohydrate Antigen 19-9 Pretreatment Lab Value
Carbohydrate Antigen (CA) 19-9 Pretreatment Lab Value records the CA 19-9 value prior to treatment. CA 19-9 is a tumor marker that has prognostic significance for pancreatic cancer.
CA 19-9 Pretreatment Lab Value is a strong predictor of resectability in the absence of metastatic disease. It is a new data item for cases diagnosed 01/01/2021+.
|0.0||0.0 Units/milliliter (U/ml) exactly|
Exact value to nearest tenth in U/ml)
|XXXX.1||10,000 U/ml or greater|
|XXXX.2||Lab value not available, physician states CA 19-9 is negative/normal|
|XXXX.3||Lab value not available, physician states CA 19-9 is positive/elevated/high|
|XXXX.7||Test ordered, results not in chart|
|XXXX.8||Not applicable: Information not collected for this case|
If this information is required by your standard setter, use of code XXXX.8 may result in an edit error.
|XXXX.9||Not documented in medical record|
CA (Carbohydrate Antigen) 19-9 Pretreatment Lab Value not assessed or unknown if assessed
|Blank||Diagnosis year is prior to 2021|
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.